Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

Clinical trial NCT04233567 · COMPLETED

Trial details

NCT number: NCT04233567
Sponsor: Sameek Roychowdhury
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Cholangiocarcinoma Metastatic Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm

Start date: 2020-01-16
Primary completion: 2023-12-12
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.